Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15
pubmed:dateCreated
2004-4-13
pubmed:abstractText
Our previous study revealed that human CYP24A1 catalyzes a remarkable metabolism consisting of both C-23 and C-24 hydroxylation pathways that used both 25(OH)D(3) and 1alpha,25(OH)(2)D(3) as substrates, while rat CYP24A1 showed extreme predominance of the C-24 over C-23 hydroxylation pathway [Sakaki, T., Sawada, N., Komai, K., Shiozawa, S., Yamada, S., Yamamoto, K., Ohyama, Y. and Inouye, K. (2000) Eur. J. Biochem. 267, 6158-6165]. In this study, by using the Escherichia coli expression system for human CYP24A1, we identified 25,26,27-trinor-23-ene-D(3) and 25,26,27-trinor-23-ene-1alpha(OH)D(3) as novel metabolites of 25(OH)D(3) and 1alpha,25(OH)(2)D(3), respectively. These metabolites appear to be closely related to the C-23 hydroxylation pathway, because human CYP24A1 produces much more of these metabolites than does rat CYP24A1. We propose that the C(24)-C(25) bond cleavage occurs by a unique reaction mechanism including radical rearrangement. Namely, after hydrogen abstraction of the C-23 position of 1alpha,25(OH)(2)D(3), part of the substrate-radical intermediate is converted into 25,26,27-trinor-23-ene-1alpha(OH)D(3), while a major part of them is converted into 1alpha,23,25(OH)(3)D(3). Because the C(24)-C(25) bond cleavage abolishes the binding affinity of 1alpha,25(OH)D(3) for the vitamin D receptor, this reaction is quite effective for inactivation of 1alpha,25(OH)D(3).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0006-2960
pubmed:author
pubmed:issnType
Print
pubmed:day
20
pubmed:volume
43
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4530-7
pubmed:dateRevised
2008-8-16
pubmed:meshHeading
pubmed-meshheading:15078099-24,25-Dihydroxyvitamin D 3, pubmed-meshheading:15078099-Animals, pubmed-meshheading:15078099-Calcitriol, pubmed-meshheading:15078099-Carbon, pubmed-meshheading:15078099-Catalysis, pubmed-meshheading:15078099-Cattle, pubmed-meshheading:15078099-Chromatography, High Pressure Liquid, pubmed-meshheading:15078099-Chromatography, Liquid, pubmed-meshheading:15078099-Cytochrome P-450 Enzyme System, pubmed-meshheading:15078099-Escherichia coli, pubmed-meshheading:15078099-Humans, pubmed-meshheading:15078099-Hydroxylation, pubmed-meshheading:15078099-Mass Spectrometry, pubmed-meshheading:15078099-Protein Binding, pubmed-meshheading:15078099-Rats, pubmed-meshheading:15078099-Receptors, Calcitriol, pubmed-meshheading:15078099-Recombinant Proteins, pubmed-meshheading:15078099-Steroid Hydroxylases, pubmed-meshheading:15078099-Substrate Specificity
pubmed:year
2004
pubmed:articleTitle
Novel metabolism of 1 alpha,25-dihydroxyvitamin D3 with C24-C25 bond cleavage catalyzed by human CYP24A1.
pubmed:affiliation
Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kitashirakawa, Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't